AUTHOR=Wang Alice S. , Jamshidi Ali O. , Oh Nathan , Sahyouni Ronald , Nowroozizadeh Behdokht , Kim Ronald , Hsu Frank P. K. , Bota Daniela 

TITLE=Somatic SMARCB1 Mutation in Sporadic Multiple Meningiomas: Case Report

JOURNAL=Frontiers in Neurology

VOLUME=9

YEAR=2018

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2018.00919

DOI=10.3389/fneur.2018.00919

ISSN=1664-2295

ABSTRACT=<p><bold>Background:</bold> Multiple intracranial meningiomas account for &lt;10% of all meningiomas. Familial multiple meningiomas have been linked to germline mutations in two genes: <italic>neurofibromatosis type 2</italic> (NF2) and <italic>SWIch/Sucrose Non-Fermentable (SWI/SNF)-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1</italic> (SMARCB1). Sporadic multiple meningiomas have been associated with somatic NF2 mutations and, to date, there has been no case related to somatic SMARCB1 mutations. Here, we describe the first case.</p><p><bold>Case Report:</bold> A 45-year-old female suffered a head trauma while snowboarding. Subsequent to her injury, she experienced persistent headache, nausea, vomiting, dizziness, and flashing lights in the right eye. Magnetic resonance imaging (MRI) of her brain revealed multiple intracranial meningiomas. She underwent a two-staged craniotomy to remove frontal/parietal/temporal and occipital extra-axial tumors. Pathology confirmed the masses as meningiomas, WHO Grade I. Tumor genetic testing was positive for SMARCB1 mutation but blood genetic testing was negative for SMARCB1 mutation.</p><p><bold>Conclusion:</bold> In sporadic multiple meningiomas, somatic NF2 mutations are usually the suspected genetic alternations. Our case illustrates that somatic SMARCB1 mutation is another genetic risk factor for sporadic multiple meningiomas, albeit rare.</p>